Search for: "IN RE WYETH" Results 421 - 440 of 702
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2012, 5:00 am by Bexis
  Two, since both Mensing and Wyeth v. [read post]
28 Dec 2007, 1:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalWTO grants Antigua and Barbuda the right to waive US intellectual property rights worth up to $21 million: (IPKat), (Against Monopoly), (IAM), (Intellectual Property Law Blog), (The Register), (Patry Copyright Blog),New year brings prospect of new WIPO leader, budget agreement: (Intellectual Property Watch),Importance of IP for development in… [read post]
28 May 2020, 5:29 am by Schachtman
Despite the confusing verbiage, these judicial rulings are a serious deviation from the text of Rule 702, as well as the Advisory Committee Note to the 2000 Amendments, which embraced the standard articulated in In re Paoli, that “any step that renders the analysis unreliable . . . renders the expert’s testimony inadmissible. [read post]
31 Oct 2011, 4:58 am by Max Kennerly, Esq.
The first two conclusions about docket size are underwhelming, which makes it even more disappointing that they’re also meaningless. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
9 May 2010, 5:15 am by Lawrence B. Ebert
If you're interested in patents, law firms and the U.S. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]